Full Text View
Tabular View
No Study Results Posted
Related Studies
The Tobramycin Study
This study has been completed.
Study NCT00257790   Information provided by Rikshospitalet HF
First Received: November 22, 2005   Last Updated: August 1, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neutropenia
Fever
Cancer
More general conditions related to this trial
Agranulocytosis
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Interventions listed in this trial
Tobramycin once a day
Additional drug interventions recognized in this trial
Tobramycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Rikshospitalet HF
The National Institute of Health, Oslo
Ullevaal University Hospital
Sorlandet Hospital HF
Sykehuset Buskerud
Sentralsjukehuset i Rogaland
Sykehuset Innlandet HF
Sentralsjukehuset i Hedemark
Per Arne Standal, Sykehuset i Vestfold, Tønsberg
Ivar Jo Hagen, Sykehuset Innlandet, Lillehammer
Sykehuset Asker og Baerum


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services